The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer-Reference-Cited by-同舟云学术

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer

Published:2015 Issue: Volume: Page:225-243
ISSN:0070-217X
Container-title:Natural Killer Cells
language:
Short-container-title:

Author:

Cichocki Frank,Verneris Michael R.,Cooley Sarah,Bachanova Veronika,Brunstein Claudio G.,Blazar Bruce R.,Wagner John,Schlums Heinrich,Bryceson Yenan T.,Weisdorf Daniel J.,Miller Jeffrey S.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/82_2015_445

Reference118 articles.

1. Appelbaum FR, Dahlberg S, Thomas ED et al (1984) Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison. Ann Intern Med 101(5):581–588

2. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296(5571):1323–1326

3. Ardolino M, Azimi CS, Iannello A et al (2014) Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest 124(11):4781–4794

4. Bachanova V, Burns LJ, McKenna DH et al (2010) Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother 59(11):1739–1744

5. Bachanova V, Cooley S, Defor TE et al (2014) Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood 123(25):3855–3863

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings;Journal for ImmunoTherapy of Cancer;2024-05

2. Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients;BMC Cancer;2023-11-10

3. Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy;CNS Neuroscience & Therapeutics;2023-06-21

4. PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells;OncoImmunology;2022-07-06

5. OMIP‐080: 29‐Color flow cytometry panel for comprehensive evaluation of NK and T cells reconstitution after hematopoietic stem cells transplantation;Cytometry Part A;2021-10-24